V022-8575 Screening compound: benzyl 3-({[2-(dimethylamino)ethyl]carbamoyl}methyl)-7-methyl-5-(3-phenoxyphenyl)-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate

V022-8575 Screening compound: benzyl 3-({[2-(dimethylamino)ethyl]carbamoyl}methyl)-7-methyl-5-(3-phenoxyphenyl)-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate
V022-8575 Screening compound: benzyl 3-({[2-(dimethylamino)ethyl]carbamoyl}methyl)-7-methyl-5-(3-phenoxyphenyl)-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-8575
benzyl 3-({[2-(dimethylamino)ethyl]carbamoyl}methyl)-7-methyl-5-(3-phenoxyphenyl)-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-8575

Molecular Formula

C33H34N4O4S (C33 H34 N4 O4 S)

Compound Name

benzyl 3-({[2-(dimethylamino)ethyl]carbamoyl}methyl)-7-methyl-5-(3-phenoxyphenyl)-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate

IUPAC name

benzyl 3-({[2-(dimethylamino)ethyl]carbamoyl}methyl)-7-methyl-5-(3-phenoxyphenyl)-5H-[13]thiazolo[32-a]pyrimidine-6-carboxylate

SMILES

CC(N=C1SC=C(CC(NCCN(C)C)=O)N1C1c2cc(Oc3ccccc3)ccc2)=C1C(OCc1ccccc1)=O

InChI

InChI=1S/C33H34N4O4S/c1-23-30(32(39)40-21-24-11-6-4-7-12-24)31(25-13-10-16-28(19-25)41-27-14-8-5-9-15-27)37-26(22-42-33(37)35-23)20-29(38)34-17-18-36(2)3/h4-16,19,22,31H,17-18,20-21H2,1-3H3,(H,34,38)/t31-/m1/s1

InChI Key

LQZNVGXSPGQKRA-WJOKGBTCSA-N

MDL Number (MFCD)

MFCD14476647

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

582.72

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.930

Distribution Coefficient, logD

3.316

Water Solubility, LogSw

-4.94

Polar Surface Area

67.441

Acid Dissociation Constant (pKa)

14.01

Base Dissociation Constant (pKb)

9.00

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.20

V022-8575 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

MCL1 Targeted Library (12200 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V022-8575 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-8575?
Check Price and Availability of V022-8575, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-8575 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-8575
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-8575
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-8575 available by request